Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer
Michael A. Moses(National Cancer Institute), Leonard Μ. Neckers(National Cancer Institute), Jane B. Trepel(National Institutes of Health), Sanjay V. Malhotra(Oregon Health & Science University), Génesis M. Rivera-Márquez(National Cancer Institute), Nancy L. Weigel(Baylor College of Medicine), Jason E. Gestwicki(University of California, San Francisco), Kristin Beebe(Center for Cancer Research), Nobu Oshima(Kyoto University), Abbey D. Zuehlke(National Cancer Institute), Catherine Wells(National Cancer Institute), Sunmin Lee(National Institutes of Health), Matthew J. Watson(National Cancer Institute), Vineet Kumar(Stanford University), Yeong Sang Kim(National Cancer Institute), William E. Bingman, Hao Shao(Institute for Neurodegenerative Disorders)
Cited by 126
Related Papers
Targeting the dynamic HSP90 complex in cancer
|Nature reviews. Cancer|2010|1.5k
Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation
|Cell|1988|598
Polyglutamine-Expanded Androgen Receptors Form Aggregates That Sequester Heat Shock Proteins, Proteasome Components and SRC-1, and Are Suppressed by the HDJ-2 Chaperone
|Human Molecular Genetics|1999|448
Androgen receptors in hormone-dependent and castration-resistant prostate cancer
|Pharmacology & Therapeutics|2013|441
Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway
|Journal of Biological Chemistry|1996|432